Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information.

Hamamoto, Ryuji; Koyama, Takafumi; Kouno, Nobuji; Yasuda, Tomohiro; Yui, Shuntaro; Sudo, Kazuki; Hirata, Makoto; Sunami, Kuniko; Kubo, Takashi; Takasawa, Ken; Takahashi, Satoshi; Machino, Hidenori; Kobayashi, Kazuma; Asada, Ken; Komatsu, Masaaki; Kaneko, Syuzo; Yatabe, Yasushi; Yamamoto, Noboru

Hamamoto, Ryuji; Koyama, Takafumi; Kouno, Nobuji; Yasuda, Tomohiro; Yui, Shuntaro; Sudo, Kazuki; Hirata, Makoto; Sunami, Kuniko; Kubo, Takashi; Takasawa, Ken; Takahashi, Satoshi; Machino, Hidenori; Kobayashi, Kazuma; Asada, Ken; Komatsu, Masaaki; Kaneko, Syuzo; Yatabe, Yasushi; Yamamoto, Noboru.

Afiliação

Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. rhamamot@ncc.go.jp.
Koyama T; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan. rhamamot@ncc.go.jp.
Kouno N; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yasuda T; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yui S; Department of Surgery, Graduate School of Medicine, Kyoto University, Yoshida-konoe-cho, Sakyo-ku, Kyoto, 606-8303, Japan.
Sudo K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Hirata M; Research and Development Group, Hitachi, Ltd., 1-280 Higashi-koigakubo, Kokubunji, Tokyo, 185-8601, Japan.
Sunami K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kubo T; Research and Development Group, Hitachi, Ltd., 1-280 Higashi-koigakubo, Kokubunji, Tokyo, 185-8601, Japan.
Takasawa K; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Takahashi S; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Machino H; Department of Genetic Medicine and Services, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kobayashi K; Department of Laboratory Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Asada K; Department of Laboratory Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Komatsu M; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kaneko S; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.
Yatabe Y; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yamamoto N; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.